Europe Orthopedic Knee market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-24
- Report ID: 143358
- Pages: 225
-
Format:
Short Description
Europe Orthopedic Knee Market, By Product Type (Knee Arthroscopy, Ligament Repair, and Others), Indication (Osteoarthritis, Cruciate and Collateral Ligament Tears, Meniscal Injuries, and Others), End User (Hospitals, Rehabilitation Centers, Orthopedic Centers, Ambulatory Surgical Centers, and Others) Industry Trends and Forecast to 2029
Market Definition:
The knee is the largest joint in the body. The upper and lower bones of the knee are separated by two discs (menisci). The upper leg bone (femur) and the lower leg bones (tibia and fibula) are connected by ligaments and tendons. Several reasons are presented, which necessitate the use of orthopedic knee instruments such as knee implants, orthoses, and aids and the use of medications such as analgesics and non-steroidal anti-inflammatory drugs (NSAIDs). The common reason for knee replacement surgery is to relieve severe pain caused by osteoarthritis, crucial and collateral ligament tears, and meniscal injuries. People who require knee replacement surgery usually have problems walking, climbing stairs, and getting in and out of chairs. Some also have knee pain at rest.
In Europe, Orthopedic diseases continue to rise throughout the globe. The common knee disease which occurs in Europe is knee osteoarthritis. Knee osteoarthritis accounts for almost four-fifths of the burden of osteoarthritis (OA) worldwide and increases with obesity and age. Knee diseases, especially knee osteoarthritis, is common and a major cause of disability among the elderly population. Up to now, knee osteoarthritis has shown to be curable except, knee arthroplasty which is considered as an effective treatment at an advanced stage of the disease. The knee arthroplasty surgery involves incision and removal of the damaged bone from the thighbone of the patient and knee cap and replacing it with artificial joint (prosthesis and implants), which are mobile and fixed bearing implants. The prosthesis and implants are composed of metal, ceramic, and plastic. The ligaments are repaired by placing them back onto the original bone in their anatomic position, by using a small anchor to attach the ligaments into the bone.
Market Segmentation:
The Europe orthopedic knee market is categorized into three segments: product type, indication, and end user.
On the basis of product type, the Europe orthopedic knee market is segmented into knee arthroscopy, ligament repair and others
On the basis of indication, the Europe orthopedic knee market is segmented into osteoarthritis, cruciate and collateral ligament tears, meniscal injuries, and others.
On the basis of end user, the Europe orthopedic knee market is segmented into hospitals, rehabilitation centers, orthopedic centers, ambulatory surgical centers and others.
Market Players
The key market players for Europe orthopedic knee market are listed below:
Zimmer Biomet.
DePuy Synthes (Johnson & Johnson)
Stryker
Smith & Nephew
Bauerfeind AG
Medacta International
B. Braun Melsungen AG
Exactech, Inc.
Otto Bock
SSUR
Bayer
MicroPort Orthopedics Inc.
AMPLITUDE SAS
Symbios Orthopdie S.A.
aap Implantate AG
GROUP FH ORTHO
CERAVER
PETER BREHM GmbH
QUOS Endoprothetik GmbH
alloPlus GmbH
TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF EUROPE ORTHOPEDIC KNEE MARKET 22
1.4 CURRENCY AND PRICING 24
1.5 LIMITATIONS 24
1.6 MARKETS COVERED 24
2 EUROPE ORTHOPEDIC KNEE MARKET: SEGMENTATION 27
2.1 MARKETS COVERED 27
2.2 GEOGRAPHICAL SCOPE 28
2.3 YEARS CONSIDERED FOR THE STUDY 28
2.4 DBMR TRIPOD DATA VALIDATION MODEL 29
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.6 MULTIVARIATE MODELLING 33
2.7 PRODUCT SEGMENT LIFELINE CURVE 33
2.8 DBMR MARKET POSITION GRID 34
2.9 MARKET END USER COVERAGE GRID 36
2.10 SECONDARY SOURCES 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 40
4.1 PESTEL 41
4.2 PORTER'S FIVE FORCES MODEL 42
4.3 PRICING STRATEGY 43
4.3.1 AVERAGE SELLING PRICE OF KNEE IMPLANTS 43
5 EUROPE ORTHOPEDIC KNEE MARKET: REGULATIONS 44
6 MARKET OVERVIEW 47
6.1 DRIVERS 49
6.1.1 RISE IN INCIDENCE OF KNEE DISEASES 49
6.1.2 RISE IN GERIATRIC POPULATION 49
6.1.3 RISE IN AWARENESS ABOUT KNEE TREATMENT IN EUROPE 50
6.1.4 RISE IN PRODUCT LAUNCHES 50
6.1.5 RISE IN NUMBER OF KNEE SURGERIES 51
6.2 RESTRAINTS 51
6.2.1 RISING COST OF ORTHOPEDIC KNEE IMPLANTS AND SURGERIES 51
6.2.2 PROBLEMS FACED WHILE USING ORTHOPEDIC KNEE MEDICATIONS AND IMPLANTS 52
6.2.3 RISE IN PRODUCT RECALL 52
6.2.4 RISE IN CONCERN REGARDING METAL SENSITIVITY IN PATIENTS WITH KNEE IMPLANTS 53
6.3 OPPORTUNITIES 53
6.3.1 STRATEGIC INITIATIVE BY MARKET PLAYERS 53
6.3.2 RISE IN HEALTHCARE EXPENDITURE 54
6.3.3 GROWTH OF TECHNOLOGICAL DEVELOPMENTS IN ORTHOPEDIC KNEE IMPLANTS 54
6.4 CHALLENGES 55
6.4.1 LACK OF SKILLED PROFESSIONALS 55
6.4.2 STRINGENT REGULATIONS 55
7 EUROPE ORTHOPEDIC KNEE MARKET, BY PRODUCT TYPE 57
7.1 OVERVIEW 58
7.2 KNEE ARTHROSCOPY 61
7.2.1 TOTAL KNEE REPLACEMENT SURGERY 61
7.2.1.1 IMPLANTS 62
7.2.1.1.1 IMPLANTS, BY TYPE 62
7.2.1.1.1.1 FIXED BEARING IMPLANTS 62
7.2.1.1.1.2 MOBILE BEARING IMPLANTS 62
7.2.1.1.1.3 MEDIAL PIVOT IMPLANTS 62
7.2.1.1.1.4 OTHERS 63
7.2.1.1.2 IMPLANTS, BY MATERIAL 63
7.2.1.1.2.1 METAL ON PLASTIC 63
7.2.1.1.2.2 METAL ON METAL 63
7.2.1.1.2.3 CERAMIC ON PLASTIC 63
7.2.1.1.2.4 CERAMIC ON CERAMIC 63
7.2.1.2 ORTHOSES AND AIDS 63
7.2.1.3 MEDICATION 63
7.2.1.3.1 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 64
7.2.1.3.2 ANALGESICS 64
7.2.1.4 OTHERS 64
7.2.2 KNEE REVISION SURGERY 64
7.2.2.1 IMPLANTS 64
7.2.2.1.1 IMPLANTS, BY TYPE 65
7.2.2.1.1.1 FIXED BEARING IMPLANTS 65
7.2.2.1.1.2 MOBILE BEARING IMPLANTS 65
7.2.2.1.1.3 MEDIAL PIVOT IMPLANTS 65
7.2.2.1.1.4 OTHERS 65
7.2.2.1.2 IMPLANTS, BY COMPONENT 65
7.2.2.1.2.1 FEMORAL 66
7.2.2.1.2.2 TIBIAL 66
7.2.2.1.2.3 PATELLAR 66
7.2.2.1.3 IMPLANTS, BY MATERIAL 66
7.2.2.1.3.1 METAL ON PLASTIC 66
7.2.2.1.3.2 METAL ON METAL 66
7.2.2.1.3.3 CERAMIC ON PLASTIC 67
7.2.2.1.3.4 CERAMIC ON CERAMIC 67
7.2.2.2 ORTHOSES AND AIDS 67
7.2.2.3 MEDICATION 67
7.2.2.3.1 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 67
7.2.2.3.2 ANALGESICS 67
7.2.2.4 OTHERS 67
7.2.3 PARTIAL KNEE REPLACEMENT SURGERY 67
7.2.3.1 IMPLANTS 68
7.2.3.1.1 IMPLANTS, BY TYPE 68
7.2.3.1.1.1 FIXED BEARING IMPLANTS 68
7.2.3.1.1.2 MOBILE BEARING IMPLANTS 68
7.2.3.1.1.3 MEDIAL PIVOT IMPLANTS 69
7.2.3.1.1.4 OTHERS 69
7.2.3.1.2 IMPLANTS, BY COMPONENT 69
7.2.3.1.2.1 FEMORAL 69
7.2.3.1.2.2 TIBIAL 69
7.2.3.1.2.3 PATELLAR 69
7.2.3.1.3 IMPLANTS, BY MATERIAL 69
7.2.3.1.3.1 METAL ON PLASTIC 70
7.2.3.1.3.2 METAL ON METAL 70
7.2.3.1.3.3 CERAMIC ON PLASTIC 70
7.2.3.1.3.4 CERAMIC ON CERAMIC 70
7.2.3.2 ORTHOSES AND AIDS 70
7.2.3.3 MEDICATION 70
7.2.3.3.1 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 71
7.2.3.3.2 ANALGESICS 71
7.2.3.4 OTHERS 71
7.3 LIGAMENT REPAIR 71
7.3.1 ANTERIOR CRUCIATE LIGAMENT (ACL) REPAIR 71
7.3.2 POSTERIOR CRUCIATE LIGAMENT (PCL) REPAIR 72
7.3.3 OTHERS 72
7.4 OTHERS 72
8 EUROPE ORTHOPEDIC KNEE MARKET, BY INDICATION 73
8.1 OVERVIEW 74
8.2 OSTEOARTHRITIS 77
8.3 CRUCIATE AND COLLATERAL LIGAMENT TEARS 77
8.4 MENISCAL INJURIES 78
8.5 OTHERS 78
9 EUROPE ORTHOPEDIC KNEE MARKET, BY END USER 79
9.1 OVERVIEW 80
9.2 HOSPITALS 83
9.3 ORTHOPEDIC CENTERS 83
9.4 AMBULATORY SURGICAL CENTERS 84
9.5 REHABILITATION CENTERS 84
9.6 OTHERS 84
10 EUROPE ORTHOPEDIC KNEE MARKET, BY COUNTRY 86
10.1 GERMANY 91
10.2 FRANCE 96
10.3 U.K. 101
10.4 SPAIN 106
10.5 ITALY 111
10.6 TURKEY 116
10.7 NETHERLANDS 121
10.8 BELGIUM 126
10.9 SWITZERLAND 131
10.10 REST OF EUROPE 136
11 EUROPE ORTHOPEDIC KNEE MARKET: COMPANY LANDSCAPE 137
11.1 COMPANY SHARE ANALYSIS: EUROPE 137
12 SWOT ANALYSIS 138
13 COMPANY PROFILE 139
13.1 ZIMMER BIOMET 139
13.1.1 COMPANY SNAPSHOT 139
13.1.2 PRODUCT PORTFOLIO 139
13.1.3 RECENT DEVELOPMENTS 140
13.2 DEPUY SYNTHES (A SUBSIDIARY OF JOHNSON AND JOHNSON SERVICES, INC) 142
13.2.1 COMPANY SNAPSHOT 142
13.2.2 REVENUE ANALYSIS 142
13.2.3 PRODUCT PORTFOLIO 143
13.2.4 RECENT DEVELOPMENT 143
13.3 STRYKER 144
13.3.1 COMPANY SNAPSHOT 144
13.3.2 REVENUE ANALYSIS 144
13.3.3 PRODUCT PORTFOLIO 145
13.3.4 RECENT DEVELOPMENTS 145
13.4 SMITH & NEPHEW 147
13.4.1 COMPANY SNAPSHOT 147
13.4.2 REVENUE ANALYSIS 147
13.4.3 PRODUCT PORTFOLIO 148
13.4.4 RECENT DEVELOPMENTS 149
13.5 BAUERFEIND 150
13.5.1 COMPANY SNAPSHOT 150
13.5.2 PRODUCT PORTFOLIO 150
13.5.3 RECENT DEVELOPMENT 151
13.6 MEDACTA INTERNATIONAL 152
13.6.1 COMPANY SNAPSHOT 152
13.6.2 REVENUE ANALYSIS 152
13.6.3 PRODUCT PORTFOLIO 153
13.6.4 RECENT DEVELOPMENTS 153
13.7 B BRAUN MELSUNGEN AG 154
13.7.1 COMPANY SNAPSHOT 154
13.7.2 REVENUE ANALYSIS 154
13.7.3 PRODUCT PORTFOLIO 155
13.7.4 RECENT DEVELOPMENT 155
13.8 EXACTECH, INC. 156
13.8.1 COMPANY SNAPSHOT 156
13.8.2 PRODUCT PORTFOLIO 156
13.8.3 RECENT DEVELOPMENTS 157
13.9 AMPLITUDE SURGICAL 158
13.9.1 COMPANY SNAPSHOT 158
13.9.2 PRODUCT PORTFOLIO 158
13.9.3 RECENT DEVELOPMENT 158
13.10 AAP IMPLANTATE AG 159
13.10.1 COMPANY SNAPSHOT 159
13.10.2 PRODUCT PORTFOLIO 159
13.10.3 RECENT DEVELOPMENT 160
13.11 ALLOPLUS GMBH 161
13.11.1 COMPANY SNAPSHOT 161
13.11.2 PRODUCT PORTFOLIO 161
13.11.3 RECENT DEVELOPMENT 161
13.12 AEQUOS ENDOPROTHETIK GMBH 162
13.12.1 COMPANY SNAPSHOT 162
13.12.2 PRODUCT PORTFOLIO 162
13.12.3 RECENT DEVELOPMENT 162
13.13 BAYER AG 163
13.13.1 COMPANY SNAPSHOT 163
13.13.2 REVENUE ANALYSIS 163
13.13.3 PRODUCT PORTFOLIO 164
13.13.4 RECENT DEVELOPMENT 164
13.14 CERAVER 165
13.14.1 COMPANY SNAPSHOT 165
13.14.2 PRODUCT PORTFOLIO 165
13.14.3 RECENT DEVELOPMENT 165
13.15 GROUP FH ORTHO 166
13.15.1 COMPANY SNAPSHOT 166
13.15.2 PRODUCT PORTFOLIO 166
13.15.3 RECENT DEVELOPMENT 167
13.16 MICROPORT ORTHOPEDICS, INC. (A SUSBSIDIARY OF MICROPORT) 168
13.16.1 COMPANY SNAPSHOT 168
13.16.2 REVENUE ANALYSIS 168
13.16.3 PRODUCT PORTFOLIO 169
13.16.4 RECENT DEVELOPMENTS 169
13.17 OSSUR 171
13.17.1 COMPANY SNAPSHOT 171
13.17.2 REVENUE ANALYSIS 171
13.17.3 PRODUCT PORTFOLIO 172
13.17.4 RECENT DEVELOPMENTS 172
13.18 OTTOBOCK 173
13.18.1 COMPANY SNAPSHOT 173
13.18.2 PRODUCT PORTFOLIO 173
13.18.3 RECENT DEVELOPMENT 173
13.19 PETER BREHM GMBH 175
13.19.1 COMPANY SNAPSHOT 175
13.19.2 PRODUCT PORTFOLIO 175
13.19.3 RECENT DEVELOPMENT 175
13.20 SYMBIOS ORTHOPDIE S.A. 176
13.20.1 COMPANY SNAPSHOT 176
13.20.2 PRODUCT PORTFOLIO 176
13.20.3 RECENT DEVELOPMENTS 176
14 QUESTIONNAIRE 177
15 RELATED REPORTS 180
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
